Ropes & Gray Represents Medtronic in $1.1 Billion Acquisition of Intersect ENT
Ropes & Gray advised global medical technology leader Medtronic plc. in an agreement to acquire all outstanding shares of Intersect ENT in an all cash transaction for an approximate value of $1.1 billion. The transaction was announced on August 6, 2021.
The acquisition will expand Medtronic’s portfolio of ear, nose and throat medical devices. Intersect ENT makes sinus implants that open sinus passageways to deliver an anti-inflammatory steroid to aid in healing for patients suffering from chronic rhinosinusitis.
The Ropes & Gray team was led by capital markets and mergers & acquisitions partners Chris Comeau and Tara Fisher (both of Boston) and mergers & acquisitions counsel Aileen Kim (New York) and included litigation & enforcement partners Mike McFalls, Jonathan Klarfeld and Samer Musallam (all of Washington, D.C.) and Ruchit Patel (London), tax partner Leo Arnaboldi (New York), employment & benefits partner Renata Ferrari (Boston), litigation & enforcement counsel Deidre Johnson (Boston) and Lisa Kaltenbrunner (London) and mergers & acquisitions associates Debbie Wang, and Matthew Stylianou (both of New York).